Amy Figueroa, CFA

Amy Figueroa, CFA is Adverum’s vice president, investor relations and corporate communications, responsible for developing and leading a strategic investor relations and communications program. With over 20 years of experience, she joins Adverum after serving as an advisor for nearly five years. Previously, she founded an advisory business, Ascent BioCommunications, LLC, helped lead Aimmune Therapeutics’ IPO, and led investor relations at Onyx Pharmaceuticals (acquired by Amgen) over a period of significant transformation and value creation. Earlier, she led investor relations and communications for Peregrine Pharmaceuticals, Dynavax Technologies, and SciClone Pharmaceuticals, and in New York worked for Merrill Lynch on the sell side and for CEMEX heading global analyst relations. She earned a BA from Willamette University and an MBA in International Management from Thunderbird School of Global Management and is a CFA Charterholder.